Syneos Health Stock Short Ratio
SYNHDelisted Stock | USD 42.31 0.07 0.17% |
Syneos Health fundamentals help investors to digest information that contributes to Syneos Health's financial success or failures. It also enables traders to predict the movement of Syneos Stock. The fundamental analysis module provides a way to measure Syneos Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Syneos Health stock.
Syneos |
Syneos Health Company Short Ratio Analysis
Syneos Health's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Syneos Health Short Ratio | 5.59 X |
Most of Syneos Health's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Syneos Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Syneos Health has a Short Ratio of 5.59 times. This is 43.33% higher than that of the Life Sciences Tools & Services sector and 3.95% lower than that of the Health Care industry. The short ratio for all United States stocks is 39.75% lower than that of the firm.
Syneos Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Syneos Health's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics of similar companies.Syneos Health is currently under evaluation in short ratio category among its peers.
Syneos Fundamentals
Return On Equity | 0.0209 | |||
Return On Asset | 0.0263 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.06 % | |||
Current Valuation | 7.23 B | |||
Shares Outstanding | 103.72 M | |||
Shares Owned By Insiders | 0.48 % | |||
Shares Owned By Institutions | 94.74 % | |||
Number Of Shares Shorted | 6.76 M | |||
Price To Earning | 18.05 X | |||
Price To Book | 1.07 X | |||
Price To Sales | 0.66 X | |||
Revenue | 5.39 B | |||
Gross Profit | 1.25 B | |||
EBITDA | 699.99 M | |||
Net Income | 266.5 M | |||
Cash And Equivalents | 124.2 M | |||
Cash Per Share | 1.21 X | |||
Total Debt | 2.9 B | |||
Debt To Equity | 0.93 % | |||
Current Ratio | 1.10 X | |||
Book Value Per Share | 33.69 X | |||
Cash Flow From Operations | 426.98 M | |||
Short Ratio | 5.59 X | |||
Earnings Per Share | 0.70 X | |||
Price To Earnings To Growth | 1.28 X | |||
Target Price | 42.5 | |||
Number Of Employees | 28.77 K | |||
Beta | 1.58 | |||
Market Capitalization | 4.43 B | |||
Total Asset | 8.2 B | |||
Retained Earnings | 167.69 M | |||
Working Capital | 219.25 M | |||
Current Asset | 1.09 B | |||
Current Liabilities | 1.07 B | |||
Z Score | 1.92 | |||
Net Asset | 8.2 B |
About Syneos Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Syneos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syneos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syneos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |